MeVis Medical Solutions AG (ETR:M3V)

ETR:M3V Cash Flow Statement

Financials in millions EUR. Fiscal year is October - September.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Income	3.17	4.56	4.92	7.79	4.55
Depreciation & Amortization	0.15	0.13	0.1	0.09	0.13
Other Operating Activities	-0.87	-1.07	-0.46	-1.62	-0.25
Change in Accounts Receivable	0.64	0.57	1.58	-1.91	3.9
Change in Accounts Payable	0.76	-0.13	0.05	-0.27	0.34
Change in Other Net Operating Assets	0.04	-0.91	-0.32	0.77	0.46
Operating Cash Flow	3.88	3.15	5.85	4.86	9.13
Operating Cash Flow Growth	23.29%	-46.25%	20.52%	-46.80%	215.97%

Investing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Capital Expenditures	-0.14	-0.3	-0.08	-0.13	-0.05
Investment in Securities	-	0.01	-	-	-
Other Investing Activities	1.09	1.2	1.07	0.19	0.16
Investing Cash Flow	0.95	0.91	0.99	0.06	0.11

Financing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Other Financing Activities	-4.56	-4.92	-7.79	-4.55	-5.7
Financing Cash Flow	-4.56	-4.92	-7.79	-4.55	-5.7

Net Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Foreign Exchange Rate Adjustments	-0.27	-0.35	-0.63	1.33	0.13
Net Cash Flow	-0	-1.22	-1.58	1.7	3.67

Free Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Free Cash Flow	3.74	2.84	5.77	4.72	9.08
Free Cash Flow Growth	31.44%	-50.74%	22.23%	-47.97%	225.78%
Free Cash Flow Margin	23.28%	16.76%	33.30%	25.18%	56.00%
Free Cash Flow Per Share	2.05	1.56	3.17	2.60	4.99
Levered Free Cash Flow	1.91	2.36	4.28	2.75	9.07
Unlevered Free Cash Flow	1.91	2.37	4.28	2.75	9.07

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash Interest Paid	-	-	-	-	0
Cash Income Tax Paid	0.11	0.29	0.12	0.17	0
Change in Working Capital	1.44	-0.47	1.3	-1.41	4.71

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error